Skip to main content
Fig. 2 | Gut Pathogens

Fig. 2

From: Fecal carriage of multidrug-resistant organisms increases the risk of hepatic encephalopathy in patients with cirrhosis: insights from gut microbiota and metabolite features

Fig. 2

The composition and diversity of fecal microbiota among healthy subjects, fecal MDRO− and MDRO + patients with cirrhosis. A Alpha diversity indices of fecal bacteria measured by Faith’s PD index and Shannon index. **** p < 0.0001, *** p < 0.001, ** p < 0.01. B Principal coordinate analysis of fecal microbiota by unweighted Unifrac distance metrics and Bray–Curtis distance. p = 0.033 by Unifrac distance metrics and p = 0.134 by Bray–Curtis distance between MDRO- and MDRO + patients. C Linear discriminant analysis (LDA) effect size (LEfSe) of differential abundance of bacterial taxa between fecal MDRO + and MDRO − patients with cirrhosis. MDRO, multidrug-resistant organism; NMDS, non-metric multidimensional scaling

Back to article page